Context Therapeutics Inc. SEC filings CNTX
Context Therapeutics Inc. has 307 filings in SEC EDGAR's recent list, going back to Mar 19, 2021. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 5, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Mar 23, 2026 | — |
| 424B5 | Prospectus supplement | Oct 24, 2025 | — |
| S-8 | Employee stock plan registration | Mar 20, 2025 | — |
| 424B5 | Prospectus supplement | Dec 2, 2024 | — |
| S-3 | Shelf registration | Nov 6, 2024 | — |
| 424B3 | Prospectus | May 31, 2024 | — |
| S-3 | Shelf registration | May 24, 2024 | — |
| S-8 | Employee stock plan registration | Mar 21, 2024 | — |
| S-8 | Employee stock plan registration | Mar 22, 2023 | — |
| 424B3 | Prospectus | Nov 14, 2022 | — |
| POS AM | Filing | Nov 9, 2022 | — |
| S-3 | Shelf registration | Nov 9, 2022 | — |
| 424B3 | Prospectus | Nov 9, 2022 | — |
| 424B3 | Prospectus | Sep 27, 2022 | — |
| 424B3 | Prospectus | Aug 11, 2022 | — |
| 424B3 | Prospectus | Aug 2, 2022 | — |
| 424B3 | Prospectus | Jun 3, 2022 | — |
| 424B3 | Prospectus | May 12, 2022 | — |
| 424B3 | Prospectus | Apr 12, 2022 | — |
| POS AM | Filing | Apr 4, 2022 | — |
| 424B3 | Prospectus | Mar 23, 2022 | — |
| S-8 | Employee stock plan registration | Mar 23, 2022 | — |
| 424B3 | Prospectus | Jan 11, 2022 | — |
| 424B4 | Prospectus | Dec 17, 2021 | — |
| S-1 | Registration statement | Dec 10, 2021 | — |
| S-8 | Employee stock plan registration | Oct 20, 2021 | — |
| 424B4 | Prospectus | Oct 20, 2021 | — |
| FWP | Free writing prospectus | Oct 18, 2021 | — |
| S-1/A | Amended registration statement | Oct 18, 2021 | — |
| FWP | Free writing prospectus | Sep 29, 2021 | — |
| S-1/A | Amended registration statement | Sep 29, 2021 | — |
| FWP | Free writing prospectus | Sep 24, 2021 | — |
| S-1/A | Amended registration statement | Sep 24, 2021 | — |
| FWP | Free writing prospectus | Sep 13, 2021 | — |
| S-1/A | Amended registration statement | Sep 13, 2021 | — |
| S-1/A | Amended registration statement | Jul 23, 2021 | — |
| FWP | Free writing prospectus | Jul 12, 2021 | — |
| FWP | Free writing prospectus | Jul 12, 2021 | — |
| FWP | Free writing prospectus | Jul 2, 2021 | — |
| S-1/A | Amended registration statement | Jul 2, 2021 | — |
| S-1/A | Amended registration statement | Jun 16, 2021 | — |
| S-1 | Registration statement | May 27, 2021 | — |
Showing 42 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CNTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Philadelphia, PA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1842952
- Former names
- Context Therapeutics LLC (until May 3, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.